Carl June, MD, the Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine in the Perelman School of Medicine at the University of Pennsylvania and director of Translational Research in Penn’s Abramson Cancer Center, will be recognized by the American Association for Cancer Research, the oldest and largest group in the country dedicated to pushing cancer research forward, with the third annual AACR-CRI Lloyd J. Old Award in Cancer Immunology at the AACR Annual Meeting in Philadelphia.

Established in 2013, the AACR-CRI Lloyd J. Old Award in Cancer Immunology is named in honor of Lloyd J. Old, a pioneer in modern tumor immunology. Each year, the award is given to an innovative immunologist who has done exceptional work and made significant contributions to the field.

June, an active AACR member and a senior editor of Cancer Immunology Research, is widely recognized as leader of the team responsible for the first successful and sustained demonstration of the use of Chimeric Antigen Receptor (CAR) T cell therapy, an investigational approach in which a patient’s own immune cells are engineered to attack their cancer.

June has published more than 350 manuscripts and has received numerous prizes and honors, including election to the Institute of Medicine in 2012, the Paul Ehrlich and Ludwig Darmstaedter Prize, the William B. Coley Award, the Karl Landsteiner Memorial Award, the Richard V. Smalley Memorial Award from the Society for Immunotherapy of Cancer, the Philadelphia Award, and the Hamdan Award for Medical Research Excellence. In 2014, he was also elected to the American Academy of Arts and Sciences.

Click here to view the full release.